Oct 20, 2023 / 07:30AM GMT
Operator
This call is being recorded. Welcome to BioGaia Q3 report for 2023. (Operator Instructions) Now, I will hand the conference over to CEO, Theresa Agnew; and CFO, Alexander Kotsinas. Please go ahead.
Theresa Agnew - BioGaia AB - President and CEO
This is Theresa Agnew. Welcome to our management statement for Q3 of 2023. I have to say I'm very excited to be here. This is my first such quarterly meeting, so excited to present the results today for BioGaia.
Just a little bit of an introduction on myself. So I became the CEO on September 25. My background, if you have researched a little about me, is mainly in health care. I've worked in healthcare my entire career and I have a science background.
I've spent about 21 years at Johnson & Johnson in the consumer sector for consumer healthcare products, OTC products as well as medical devices. My experience there spans marketing, sales, general management, strategic planning, business development as well. I also spent a brief period at Essilor which is the number-one manufacturer of prescription
Q3 2023 Biogaia AB Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot